POG 9005, arm A

Phase III Comparison of Intensification with Intravenous MP plus Intermediate-Dose Intravenous MTX vs Low-Dose Oral MTX Following Induction with PRED/VCR/ASP in Children with Low-Risk ALL.

This trial on the cancer.gov site.

low-risk ALL, as defined by:

(more details on cancer.gov site)

Date initiated, # of patients: (revised 1992, used 1996)

POG 9005


not given, but in 9201: pulses of another 2-drug combination (prednisone and vincristine)

Back to ALL Trials page

Ped-Onc Resource Center Home

General Disclaimer : These pages are intended for informational purposes only and are not intended to render medical advice. The information provided on Ped Onc Resource Center should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you suspect your child has a health problem, you should consult your health care provider.

Last Updated 4/06

email the editor